Skip to content

Clinical trials

Observational Leukemia, Mast-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Phase: Observational Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20071
20083
20093
20102
20141
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Withdrawn2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation2
Children's Oncology Group2
UNC Lineberger Comprehensive Cancer Center2
Adelphi Values LLC1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
Institut Català d'Oncologia1
Rutgers, The State University of New Jersey1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Mast-Cell16
Leukemia, Biphenotypic, Acute13
Leukemia, Hairy Cell13
Leukemia, Large Granular Lymphocytic13
Leukemia, Lymphocytic, Chronic, B-Cell13
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative13
Leukemia, Prolymphocytic13
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Congenital Abnormalities11
Leukemia, Myeloid, Acute11

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.